Generate a tailored SOP for Dr. Murray Grossman. Improve your application with a focused, well-structured draft.
Murray Grossman holds dual degrees in medicine and education, with extensive training in neuropsychology. He is a prominent figure in the Department of Neurology at the Perelman School of Medicine, University of Pennsylvania, where he leads the Penn Frontotemporal Degeneration Center. His research primarily focuses on biomarker studies in neurodegenerative diseases, particularly within the frontotemporal degeneration spectrum. This includes investigating conditions such as primary progressive aphasia, behavioral variant frontotemporal degeneration, and amyotrophic lateral sclerosis, with the aim of identifying behavioral, imaging, and biofluid measures that correlate with underlying proteinopathies. His expertise also encompasses young-onset neurodegenerative disorders and parkinsonian spectrum diseases. Grossman has been instrumental in clinical treatment trials aimed at advancing knowledge and treatment strategies within this critical area of neurology.
Penn Frontotemporal Degeneration Center • Philadelphia, PA
Lead clinical and research initiatives focused on frontotemporal degeneration and related neurodegenerative conditions.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.